Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$5.10 and last traded at C$5.10, with a volume of 128735 shares trading hands. The stock had previously closed at C$5.10.
Medexus Pharmaceuticals Stock Performance
The stock has a 50 day moving average price of C$4.07 and a 200 day moving average price of C$3.42. The company has a market capitalization of C$165.58 million, a P/E ratio of -74.71 and a beta of 0.53.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
- Why the Comcast Spin-Off Won’t Fix What’s Actually Broken
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
